Steward Partners Investment Advisory, LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1723397 STAMFORD, CT

Position in SPRY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,030,086

-$145,931 QoQ

Shares Held

128,600

-12.2% QoQ

Ownership

0.129%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#51

of 208 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Steward Partners Investment Advisory, LLC holds $58,588,979 across 162 Biotechnology names. SPRY ranks #13 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	351,178	$13,699,453
2	VRTX	Vertex Pharmaceuticals Inc / Ma	20,851	$10,357,317
3	ARGX	Argenx SE	9,982	$9,261,000
4	REGN	Regeneron Pharmaceuticals, Inc.	5,148	$3,209,983
5	BMRN	Biomarin Pharmaceutical Inc	55,012	$3,147,786
6	CRMD	CorMedix Inc.	232,615	$1,826,027
7	OCUL	Ocular Therapeutix, Inc	165,142	$1,621,694
8	NKTR	Nektar Therapeutics	18,279	$1,276,056

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,030,086	128,600	-12.2%	Shares	Sole	2026-08-13
2026-03-31	$1,176,017	146,453	-32.3%	Shares	Sole	2026-05-08
2025-12-31	$2,519,848	216,296	+47.4%	Shares	Sole	2026-02-12
2025-09-30	$1,474,254	146,692	+14.4%	Shares	Sole	2025-11-12
2025-06-30	$2,236,741	128,180	+164.4%	Shares	Sole	2025-08-12
2025-03-31	$609,878	48,480	+27.4%	Shares	Sole	2025-05-13
2024-12-31	$401,427	38,050	+47.2%	Shares	Sole	2025-02-06
2024-09-30	$374,825	25,850	+2054.2%	Shares	Sole	2024-11-14
2024-06-30	$10,212	1,200	-7.7%	Shares	Sole	2024-08-08
2024-03-31	$13,286	1,300	0.0%	Shares	Sole	2024-05-15
2023-12-31	$7,124	1,300	0.0%	Shares	Sole	2024-02-12
2023-09-30	$4,914	1,300	0.0%	Shares	Sole	2023-11-13
2023-06-30	$8,710	1,300	+8.3%	Shares	Sole	2023-08-14
2023-03-31	$7,812	1,200	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.